FDA inspection
Stelis Biopharma Limited: FDA inspection ending Jul 19, 2022
FDA inspection 1175245 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1175245 |
|---|---|
| Firm | Stelis Biopharma Limited |
| FEI number | 3017501030 |
| Address | Plot No.: 2-D1, Obadenahalli, Doddaballapura, 3rd Phase, Kiadb Industrial Area, Doddaballapura Taluk |
| City | Bengaluru |
| Fiscal year | 2022 |
| Inspection end date | Jul 19, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data